Article Per Year (5 Year)
p-Index From 2020 - 2025
0.562
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran Cermin Dunia Kedokteran
Vidya Gani Wijaya
Fakultas Kedokteran dan Ilmu Kesehatan, Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia
Health Professions Medicine & Pharmacology Public Health

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

 1 
Pengaruh Coronavirus Disease 2019 (COVID-19) terhadap Fungsi Kognitif Vidya Gani Wijaya; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 49, No 2 (2022): Infeksi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i2.1743

Abstract

Pasien COVID-19 memiliki gejala bervariasi. Saat ini, selain ditemukan gejala pada sistem pernapasan dan pencernaan, gejala di sistem organ lain pun mulai banyak ditemukan, salah satunya pada sistem saraf dengan gejala neurologis yang bervariasi seperti anosmia (sering), stroke, nyeri kepala, kejang, dan penurunan fungsi kognitif. Tata laksana pasien dengan penurunan fungsi kognitif masih diteliti. Beberapa pilihan terapi di antaranya human recombinant erythropoietin, flavonoid, dan terapi imun (IVIg) yang masih kontroversial. COVID-19 patients have varied symptoms. At present, in addition to symptoms in the respiratory and digestive systems, symptoms in other organ systems have begun to be found, one of which is in the nervous system with various neurological symptoms such as anosmia (frequent), stroke, headaches, seizures, and decreased cognitive function. Management of patients with decreased cognitive function is still being studied. Several therapeutic options include human recombinant erythropoietin, flavonoids, and immune therapy (IVIg), which are still controversial.
Pengaruh Coronavirus Disease 2019 (COVID-19) terhadap Fungsi Kognitif Vidya Gani Wijaya; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 49 No 2 (2022): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i2.196

Abstract

Pasien COVID-19 memiliki gejala bervariasi. Saat ini, selain ditemukan gejala pada sistem pernapasan dan pencernaan, gejala di sistem organ lain pun mulai banyak ditemukan, salah satunya pada sistem saraf dengan gejala neurologis yang bervariasi seperti anosmia (sering), stroke, nyeri kepala, kejang, dan penurunan fungsi kognitif. Tata laksana pasien dengan penurunan fungsi kognitif masih diteliti. Beberapa pilihan terapi di antaranya human recombinant erythropoietin, flavonoid, dan terapi imun (IVIg) yang masih kontroversial. COVID-19 patients have varied symptoms. At present, in addition to symptoms in the respiratory and digestive systems, symptoms in other organ systems have begun to be found, one of which is in the nervous system with various neurological symptoms such as anosmia (frequent), stroke, headaches, seizures, and decreased cognitive function. Management of patients with decreased cognitive function is still being studied. Several therapeutic options include human recombinant erythropoietin, flavonoids, and immune therapy (IVIg), which are still controversial.
Pengaruh Coronavirus Disease 2019 (COVID-19) terhadap Fungsi Kognitif Vidya Gani Wijaya; Budi Riyanto Wreksoatmodjo
Cermin Dunia Kedokteran Vol 49 No 2 (2022): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i2.196

Abstract

Pasien COVID-19 memiliki gejala bervariasi. Saat ini, selain ditemukan gejala pada sistem pernapasan dan pencernaan, gejala di sistem organ lain pun mulai banyak ditemukan, salah satunya pada sistem saraf dengan gejala neurologis yang bervariasi seperti anosmia (sering), stroke, nyeri kepala, kejang, dan penurunan fungsi kognitif. Tata laksana pasien dengan penurunan fungsi kognitif masih diteliti. Beberapa pilihan terapi di antaranya human recombinant erythropoietin, flavonoid, dan terapi imun (IVIg) yang masih kontroversial. COVID-19 patients have varied symptoms. At present, in addition to symptoms in the respiratory and digestive systems, symptoms in other organ systems have begun to be found, one of which is in the nervous system with various neurological symptoms such as anosmia (frequent), stroke, headaches, seizures, and decreased cognitive function. Management of patients with decreased cognitive function is still being studied. Several therapeutic options include human recombinant erythropoietin, flavonoids, and immune therapy (IVIg), which are still controversial.
Co-Authors Budi Riyanto Wreksoatmodjo, Budi Riyanto